<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Foreign Pharmacy News Section - International Drug Mart</title>
    <link>http://www.internationaldrugmart.com/news-section/pharmacy-news-health-articles.html</link>
    <description>The latest news | arcticles from International Drug Mart, one of the leading Foreign Pharmacies </description>
    <pubDate>Mon, 25 July 2011 11:00:00 GMT</pubDate>
    <ttl>60</ttl>
    <image>
      <title>Foreign Pharmacy News | Articles - International Drug Mart</title>
      <link>http://www.internationaldrugmart.com/news-section/pharmacy-news-health-articles.html</link>
      <url>http://wwww.internationaldrugmart.com/images/logo/idm-logo-news.jpg</url>
      <width>144</width>
      <height>36</height>
    </image><item>
<title>Strides Arcolab Gets USFDA Nod to Sell Cancer Drug in US</title>
<link>http://www.internationaldrugmart.com/news-section/strides-arcolab-gets-usfda-nod-to-sell-cancer-drug-in-us.shtml</link>
<description>Onco Therapies Ltd, a wholly owned subsidiary of Strides Arcolab, has received the US Food and Drug Administration (USFDA)</description>
<pubDate>2012-05-04</pubDate>
<guid>strides-arcolab-gets-usfda-nod-to-sell-cancer-drug-in-us.shtml</guid>
</item><item>
<title>No link between Gum Disease and Heart Disease, reports say</title>
<link>http://www.internationaldrugmart.com/news-section/no-link-between-gum-disease-and-heart-disease-reports-say.shtml</link>
<description>According to a new statement issued by the American Heart Association (AHA), there is no conclusive scientific evidence to</description>
<pubDate>2012-05-03</pubDate>
<guid>no-link-between-gum-disease-and-heart-disease-reports-say.shtml</guid>
</item><item>
<title>GlaxoSmithKline Plans to Build Biopharm Factory in the UK</title>
<link>http://www.internationaldrugmart.com/news-section/glaxosmithKline-Plans-to-build-biopharm-factory-in-the-uk.shtml</link>
<description>GlaxoSmithKline, a major pharmaceutical company, has announced to build its first new manufacturing plant in the UK in nearly</description>
<pubDate>2012-04-02</pubDate>
<guid>glaxosmithKline-Plans-to-build-biopharm-factory-in-the-uk.shtml</guid>
</item><item>
<title>Sun Pharma Advanced Research Company Announces Rights Issue to Conduct Clinical Trial of Paclitaxel in US</title>
<link>http://www.internationaldrugmart.com/news-section/sun-pharma-advanced-research-company-announces-rights-issue-to-conduct-clinical-trial-of-paclitaxel-in-us.shtml</link>
<description>Sun Pharma Advanced Research Company (SPARC), an India-based publicly listed pharma research company, has announced that it will issue additional shares to fund</description>
<pubDate>2012-03-14</pubDate>
<guid>sun-pharma-advanced-research-company-announces-rights-issue-to-conduct-clinical-trial-of-paclitaxel-in-us.shtml</guid>
</item><item>
<title>US FDA Approves Novartis' Gleevec Drug Label Change</title>
<link>http://www.internationaldrugmart.com/news-section/us-fda-approves-novartis-gleevec-drug-label-change.shtml</link>
<description>Novartis announces the US Food and Drug Administration (FDA) approval of the label change for its anti-cancer drug Gleevec</description>
<pubDate>2012-02-20</pubDate>
<guid>us-fda-approves-novartis-gleevec-drug-label-change.shtml</guid>
</item><item>
<title>Attention Deficit Hyperactivity Disorder Drugs in Short Supply, reports FDA</title>
<link>http://www.internationaldrugmart.com/news-section/attention-deficit-hyperactivity-disorder-drugs-in-short-supply-reports-fda.shtml</link>
<description>The US Food and Drug Administration (FDA) has reported that medicines used for treating attention deficit hyperactivity</description>
<pubDate>2012-01-09</pubDate>
<guid>attention-deficit-hyperactivity-disorder-drugs-in-short-supply-reports-fda.shtml</guid>
</item><item>
<title>Ranbaxy gets FDA approval to launch Lipitor's generic version in US</title>
<link>http://www.internationaldrugmart.com/news-section/ranbaxy-gets-fda-approval-to-launch-lipitors-generic-version-in-us.shtml</link>
<description>Ranbaxy Pharmaceuticals Inc., India's largest drugmaker, announced that it has received final approval from the US Food</description>
<pubDate>2012-01-04</pubDate>
<guid>ranbaxy-gets-fda-approval-to-launch-lipitors-generic-version-in-us.shtml</guid>
</item><item>
<title>World's First Malaria Vaccine Shows Promising Results</title>
<link>http://www.internationaldrugmart.com/news-section/worlds-first-malaria-vaccine-shows-promising-results.shtml</link>
<description>Malaria is a life-threatening disease that kills nearly 800,000 people a year worldwide, most of whom are children in Africa.</description>
<pubDate>2011-10-31</pubDate>
<guid>worlds-first-malaria-vaccine-shows-promising-results.shtml</guid>
</item><item>
<title>Ranbaxy Launches Generic Esomeprazole Drug in the UK</title>
<link>http://www.internationaldrugmart.com/news-section/ranbaxy-launches-generic-esomeprazole-drug-in-the-uk.shtml</link>
<description>Ranbaxy (UK) Ltd has launched generic esomeprazole tablets in the UK, 
which is offered in the strengths of 20mg and 40mg</description>
<pubDate>2011-09-21</pubDate>
<guid>ranbaxy-launches-generic-esomeprazole-drug-in-the-uk.shtml</guid>
</item><item>
<title>Majority of US Hospitals Face Drug Shortages, Survey Reports</title>
<link>http://www.internationaldrugmart.com/news-section/majority-of-us-hospitals-face-drug-shortages-survey-reports.shtml</link>
<description>Recent survey by the American Hospital Association reports that majority of the US hospitals have been facing shortage of life-saving drugs in the past six months. Owing to unprecedented drug shortage</description>
<pubDate>2011-08-04</pubDate>
<guid>majority-of-us-hospitals-face-drug-shortages-survey-reports.shtml</guid>
</item><item>
<title>Sun Pharma Gets USFDA Approval to Market Generic Uroxatral ER Tablets in the US</title>
<link>http://www.internationaldrugmart.com/news-section/sun-pharma-received-us-fda-approval-for-generic-uroxatral.shtml</link>
<description>Sun Pharmaceutical Industries Ltd has received US Food and Drug Administration (USFDA) nod to market generic version of Uroxatral (Alfuzosin Hydrochloride) tablets in the US. These are extended releas</description>
<pubDate>2011-07-25</pubDate>
<guid>sun-pharma-received-us-fda-approval-for-generic-uroxatral.shtml</guid>
</item><item>
<title>Combo Vaccine “Boostrix” Approved by FDA – To Prevent Tetanus, Diphtheria and Pertussis in Seniors</title>
<link>http://www.internationaldrugmart.com/news-section/boostrix-vaccine-approved-by-fda-for-seniors.shtml</link>
<description>The U.S. Food and Drug Administration (FDA) has approved Boostrix, a combination vaccine, to prevent tetanus, diphtheria and pertussis in adults aged 65 years and over. It is the first triple vaccine </description>
<pubDate>2011-07-13</pubDate>
<guid>boostrix-vaccine-approved-by-fda-for-seniors.shtml</guid>
</item><item>
<title>Approval for Cancer Drugs Faster in US than in Europe — Finds A Study</title>
<link>http://www.internationaldrugmart.com/news-section/approval-for-cancer-drugs-faster-in-us-than-in-europe.shtml</link>
<description>Cancer is a deadly disease caused by the uncontrolled growth of abnormal cells in the body. Anticancer drugs are vital in controlling the growth of cancerous cells.</description>
<pubDate>2011-06-23</pubDate>
<guid>approval-for-cancer-drugs-faster-in-us-than-in-europe.shtml</guid>
</item><item>
<title>Pfizer in Court to Protect Viagra Patent</title>
<link>http://www.internationaldrugmart.com/news-section/pfizer-in-court-to-protect-viagra-patent.shtml</link>
<description>Pfizer’s Viagra, hailed as the ultimate aphrodisiac, is dispensed as a prescription drug in about 110 countries worldwide for the treatment of male erectile dysfunction/impotence and pulmonary arter</description>
<pubDate>2011-06-20</pubDate>
<guid>pfizer-in-court-to-protect-viagra-patent.shtml</guid>
</item><item>
<title>Two New Melanoma Drugs Show Boost in Survival Rate</title>
<link>http://www.internationaldrugmart.com/news-section/two-new-melanoma-drugs-show-boost-in-survival-rate.shtml</link>
<description>Melanoma, the deadliest form of skin cancer, is on the rise, with an estimated 8,700 melanoma deaths in the United States last year. Here is a good news for people suffering from melanoma. Two novel d</description>
<pubDate>2011-06-07</pubDate>
<guid>two-new-melanoma-drugs-show-boost-in-survival-rate.shtml</guid>
</item><item>
<title>Antiviral Nasal Spray Effective for Common Cold – A New Finding from A Pilot Clinical Trial</title>
<link>http://www.internationaldrugmart.com/news-section/antiviral-nasal-spray-effective-for-common-cold.shtml</link>
<description>Common cold, medically referred to as a viral upper respiratory tract infection, is the most commonly occurring illness in the world. It is a most prevalent contagious viral disease that is a primary </description>
<pubDate>2011-06-01</pubDate>
<guid>antiviral-nasal-spray-effective-for-common-cold.shtml</guid>
</item><item>
<title>Viagra May Reduce Multiple Sclerosis Symptoms - Suggests a New Study</title>
<link>http://www.internationaldrugmart.com/news-section/viagra-may-reduce-multiple-sclerosis-symptoms.shtml</link>
<description>Researchers  at The Autonomous University of Barcelona (UAB) have discovered that Viagra (sildenafil citrate) and several generic versions of Viagra, with the main ingredient sildenafil citrate, immen</description>
<pubDate>2011-05-25</pubDate>
<guid>viagra-may-reduce-multiple-sclerosis-symptoms.shtml</guid>
</item><item>
<title>Ban mobile phones and wireless networks in schools, say European leaders</title>
<link>http://www.internationaldrugmart.com/news-section/ban-mobile-phones-wireless-networks-in-schools-european-country.shtml</link>
<description>Mobile phones and computers with wireless internet connections pose a risk to human health and should be banned from schools, a powerful European body has ruled.</description>
<pubDate>2011-05-18</pubDate>
<guid>ban-mobile-phones-wireless-networks-in-schools-european-country.shtml</guid>
</item><item>
<title>FDA Approves Merck’s New Drug Victrelis For Treatment Of Hepatitis C</title>
<link>http://www.internationaldrugmart.com/news-section/fda-approves-mercks-new-drug-victrelis-for-treatment-of-hepatitis-c.shtml</link>
<description>The U.S. Food and Drug Administration (FDA) announced late yesterday that it has approved Victrelis for the treatment of hepatitis C.</description>
<pubDate>2011-05-18</pubDate>
<guid>fda-approves-mercks-new-drug-victrelis-for-treatment-of-hepatitis-c.shtml</guid>
</item><item>
<title>Mylan Pharma rolls out muscle relaxant drug</title>
<link>http://www.internationaldrugmart.com/news-section/mylan-pharma-rolls-out-muscle-relaxant-drug.shtml</link>
<description>AstraZeneca has received the US Food and Drug Administration's (FDA) approval for the use of Nexium I.V. (esomeprazole sodium) for injection for the treatment of children 1 month to 17 years old who a</description>
<pubDate>2011-05-18</pubDate>
<guid>mylan-pharma-rolls-out-muscle-relaxant-drug.shtml</guid>
</item><item>
<title>Patients reveal agony of toxic hip implants</title>
<link>http://www.internationaldrugmart.com/news-section/patients-reveal-agony-of-toxic-hip-implants.shtml</link>
<description>A medical scandal that has resulted in hundreds of patients being poisoned and seriously disabled may soon lead to changes in the way medical devices are approved for use in Australia.</description>
<pubDate>2011-05-18</pubDate>
<guid>patients-reveal-agony-of-toxic-hip-implants.shtml</guid>
</item><item>
<title>AstraZeneca GERD drug receives FDA approval</title>
<link>http://www.internationaldrugmart.com/news-section/astrazeneca-gerd-drug-receives-fda-approval.shtml</link>
<description>AstraZeneca has received the US Food and Drug Administration's (FDA) approval for the use of Nexium I.V. (esomeprazole sodium) for injection for the treatment of children 1 month to 17 years old who a</description>
<pubDate>2011-05-04</pubDate>
<guid>astrazeneca-gerd-drug-receives-fda-approval.shtml</guid>
</item><item>
<title>BMA Scotland warning over alcohol risks</title>
<link>http://www.internationaldrugmart.com/news-section/bma-scotland-warning-over-alcohol-risks.shtml</link>
<description>A BMA Scotland survey suggested that on one day last month GPs saw more than 5,500 patients where alcohol had contributed to their ill health.</description>
<pubDate>2011-05-04</pubDate>
<guid>bma-scotland-warning-over-alcohol-risks.shtml</guid>
</item><item>
<title>FDA OKs New Diabetes Pill From Boehringer, Lilly</title>
<link>http://www.internationaldrugmart.com/news-section/fda-oks-new-diabetes-pill-from-boehringer.shtml</link>
<description>The Food and Drug Administration has approved a new diabetes pill from Boehringer Ingelheim and Eli Lilly for patients who can't control their blood sugar with older medicines.</description>
<pubDate>2011-05-04</pubDate>
<guid>fda-oks-new-diabetes-pill-from-boehringer.shtml</guid>
</item><item>
<title>Glenmark gets final US FDA nod for generic Cutivate lotion</title>
<link>http://www.internationaldrugmart.com/news-section/glenmark-gets-final-us-fda-nod-for-generic-cutivate-lotion.shtml</link>
<description>Glenmark Generics Inc, the US arm of India’s Glenmark Pharmaceuticals, has received final approval from US Foods and Drugs Administration for its Abbreviated New Drug Application (ANDA) for Fluticas</description>
<pubDate>2011-05-04</pubDate>
<guid>glenmark-gets-final-us-fda-nod-for-generic-cutivate-lotion.shtml</guid>
</item><item>
<title>Plan B for Emergency Situations</title>
<link>http://www.internationaldrugmart.com/news-section/plan-b-for-emergency-situations.shtml</link>
<description>A bad accident always happens. But the worse case is when you don't want to get pregnant. "Plan B" or "Morning-After Pill" is always there to help you. Not only this, when the Morning-After is taken i</description>
<pubDate>2011-05-04</pubDate>
<guid>plan-b-for-emergency-situations.shtml</guid>
</item><item>
<title>Watson Pharma launches generic of J&J's Concerta</title>
<link>http://www.internationaldrugmart.com/news-section/watson-pharma-launches-generic-of-j-and-j-s-concerta.shtml</link>
<description>Watson Pharmaceuticals Inc. said Monday it has started selling an authorized generic version of Johnson & Johnson's attention deficit hyperactivity disorder drug Concerta.</description>
<pubDate>2011-05-04</pubDate>
<guid>watson-pharma-launches-generic-of-j-and-j-s-concerta.shtml</guid>
</item><item>
<title>Adventrx Pharma Acquiring SynthRx</title>
<link>http://www.internationaldrugmart.com/news-section/adventrx-pharma-takes-over-synthrx.shtml</link>
<description>Adventrx Pharmaceuticals, a specialty pharmaceutical company engaged in acquiring, developing and commercializing proprietary product candidates, has taken over SynthRx, under a definitive merger agre</description>
<pubDate>2011-04-15</pubDate>
<guid>adventrx-pharma-takes-over-synthrx.shtml</guid>
</item><item>
<title>FDA Okays First Dengue Fever Test</title>
<link>http://www.internationaldrugmart.com/news-section/fda-okays-first-dengue-fever-test.shtml</link>
<description>The FDA has cleared the first test to diagnose patients with signs and symptoms of dengue fever.</description>
<pubDate>2011-04-15</pubDate>
<guid>fda-okays-first-dengue-fever-test.shtml</guid>
</item><item>
<title>Kids' wrist size tied to heart health</title>
<link>http://www.internationaldrugmart.com/news-section/kids-wrist-size-tied-to-heart-health.shtml</link>
<description>The size of a child's wrist may offer clues to future heart health.</description>
<pubDate>2011-04-15</pubDate>
<guid>kids-wrist-size-tied-to-heart-health.shtml</guid>
</item><item>
<title>Merck gets FDA nod for skin cancer drug</title>
<link>http://www.internationaldrugmart.com/news-section/merck-gets-fda-nod-for-skin-cancer-drug.shtml</link>
<description>Merck & Co Inc said the U.S. health regulator approved its drug to treat skin cancer in patients with node-positive melanoma, following removal of the affected part.</description>
<pubDate>2011-04-15</pubDate>
<guid>merck-gets-fda-nod-for-skin-cancer-drug.shtml</guid>
</item><item>
<title>Watson Pharma Applies To Make Generic Vigamox</title>
<link>http://www.internationaldrugmart.com/news-section/watson-pharma-applies-to-make-generic-Vigamox.shtml</link>
<description>Watson Pharmaceuticals is seeking federal approval to make a generic version of Alcon Inc.'s eye treatment, the company said Friday, just one day after Alcon filed a patent lawsuit against Watson.</description>
<pubDate>2011-04-15</pubDate>
<guid>watson-pharma-applies-to-make-generic-Vigamox.shtml</guid>
</item><item>
<title>Fake Chinese drugs with 'made in India' labels continue to hit African markets, says Nigerian FDA chief</title>
<link>http://www.internationaldrugmart.com/news-section/fake-chinese-drugs-with-made-in-India-labels-continue-to-hit-african-markets.shtml</link>
<description>The fake drugs with 'made in India' labels but purportedly made by Chinese continue to flood the African markets, especially Nigeria, according to Dr Paul B Ohri, the director general of National Agen</description>
<pubDate>2011-03-25</pubDate>
<guid>fake-chinese-drugs-with-made-in-India-labels-continue-to-hit-african-markets.shtml</guid>
</item><item>
<title>FDA panel backs NovoCure's cancer treatment device</title>
<link>http://www.internationaldrugmart.com/news-section/fda-panel-backs-novocures-cancer-treatment-device.shtml</link>
<description>NovoCure Ltd announced that the US Food and Drug Administration (FDA) Neurological Devices Advisory Panel voted that its device for treating supra-tentorial glioblastoma multiforme (GBM) tumors is saf</description>
<pubDate>2011-03-25</pubDate>
<guid>fda-panel-backs-novocures-cancer-treatment-device.shtml</guid>
</item><item>
<title>FDA panel weighs menthol cigarette ban</title>
<link>http://www.internationaldrugmart.com/news-section/fda-panel-weighs-menthol-cigarette-ban.shtml</link>
<description>Despite evidence that menthol cigarettes are a significant factor in the rise of smoking among adolescents, a federal advisory panel on Friday stopped short of recommending a ban on the cigarettes.</description>
<pubDate>2011-03-25</pubDate>
<guid>fda-panel-weighs-menthol-cigarette-ban.shtml</guid>
</item><item>
<title>New method delivers Alzheimer’s drug to the brain</title>
<link>http://www.internationaldrugmart.com/news-section/new-method-delivers-alzheimers-drug-to-the-brain.shtml</link>
<description>Oxford University scientists have developed a new method for delivering complex drugs directly to the brain, a necessary step for treating diseases like Alzheimer’s, Parkinson’s, Motor Neuron Dise</description>
<pubDate>2011-03-25</pubDate>
<guid>new-method-delivers-alzheimers-drug-to-the-brain.shtml</guid>
</item><item>
<title>Aratana Therapeutics buys health product licenses from RaQualia Pharma</title>
<link>http://www.internationaldrugmart.com/news-section/aratana-therapeutics-buys-health-product-licenses-from-raqualia-pharma.shtml</link>
<description>Aratana Therapeutics Inc. has bought the licenses for two Japanese products to develop the compounds for companion animal use.</description>
<pubDate>2011-03-07</pubDate>
<guid>aratana-therapeutics-buys-health-product-licenses-from-raqualia-pharma.shtml</guid>
</item><item>
<title>AstraZeneca and Galderma Enter into R&D Collaboration to Develop New Treatments for Dermatological Diseases</title>
<link>http://www.internationaldrugmart.com/news-section/astrazeneca-and-galderma-enter-into-r-and-d-collaboration.shtml</link>
<description>AstraZeneca and Galderma Pharma S.A. (Galderma), a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments</description>
<pubDate>2011-03-07</pubDate>
<guid>astrazeneca-and-galderma-enter-into-r-and-d-collaboration.shtml</guid>
</item><item>
<title>FDA warns of birth defects with use of J&J's Topamax</title>
<link>http://www.internationaldrugmart.com/news-section/fda-warns-of-birth-defects-with-use-of-J-and-J-s-topamax.shtml</link>
<description>The FDA has slapped a birth-defect warning on Johnson & Johnson's Topamax drug, saying doctors should reconsider prescribing the drug to women of childbearing age. Approved to treat epileptic seizures</description>
<pubDate>2011-03-07</pubDate>
<guid>fda-warns-of-birth-defects-with-use-of-J-and-J-s-topamax.shtml</guid>
</item><item>
<title>Pharma research in ‘late stages’ of 460 rare disease treatments</title>
<link>http://www.internationaldrugmart.com/news-section/pharma-research-in-late-stages-of-460-rare-disease-treatments.shtml</link>
<description>Around 460 medicines to treat rare diseases are in the late stages of development, and have the potential to change the pharmaceutical processing supply chain.</description>
<pubDate>2011-03-07</pubDate>
<guid>pharma-research-in-late-stages-of-460-rare-disease-treatments.shtml</guid>
</item><item>
<title>Impax gets FDA approval for antibiotic</title>
<link>http://www.internationaldrugmart.com/news-section/impax-gets-fda-approval-for-antibiotic.shtml</link>
<description>HAYWARD, Calif. (AP) — Impax Laboratories Inc. said Friday it received Food and Drug Administration approval for a generic version of 150-milligram capsules of the antibiotic Adoxa, which is used to</description>
<pubDate>2011-02-24</pubDate>
<guid>impax-gets-fda-approval-for-antibiotic.shtml</guid>
</item><item>
<title>Sanofi-Aventis, International Vaccine Institute Partner</title>
<link>http://www.internationaldrugmart.com/news-section/sanofi-aventis-international-vaccine-institute-partner.shtml</link>
<description>Sanofi Pasteur, the vaccines division of pharma company Sanofi-Aventis Group, is partnering with the International Vaccine Institute to support the recently launched Dengue Vaccine Initiative.</description>
<pubDate>2011-02-24</pubDate>
<guid>sanofi-aventis-international-vaccine-institute-partner.shtml</guid>
</item><item>
<title>Unhealthy carbonated beverage issue gains momentum in the US</title>
<link>http://www.internationaldrugmart.com/news-section/unhealthy-carbonated-beverage-issue-gains-momentum-in-the-us.shtml</link>
<description>The ‘caramel colouring’ used in Coca-Cola, Pepsi and other dark coloured soft drinks contains a ‘carcinogenic’ substance which causes cancer. The Centre for Science in the Public Interest (CSP</description>
<pubDate>2011-02-24</pubDate>
<guid>unhealthy-carbonated-beverage-issue-gains-momentum-in-the-us.shtml</guid>
</item><item>
<title>FDA Approves New Test to Monitor Level of Drug in Kidney Transplant Patients</title>
<link>http://www.internationaldrugmart.com/news-section/fda-approves-new-test-to-monitor-level-of-drug-in-kidney-transplant-patients.shtml</link>
<description>The US Food and Drug Administration has revealed that it has approved a new test which will monitor the level of a drug which is used in kidney transplant patients to prevent the rejection of the tran</description>
<pubDate>2011-02-17</pubDate>
<guid>fda-approves-new-test-to-monitor-level-of-drug-in-kidney-transplant-patients.shtml</guid>
</item><item>
<title>First 3-D Mammogram Device is Approved by the FDA</title>
<link>http://www.internationaldrugmart.com/news-section/first-3-d-mammogram-device-is-approved-by-the-fda.shtml</link>
<description>On Friday, the first three-dimensional mammogram was approved by the U.S. Food and Drug Administration. This is big news for breast cancer patients because it will allow doctors to diagnose and detect</description>
<pubDate>2011-02-17</pubDate>
<guid>first-3-d-mammogram-device-is-approved-by-the-fda.shtml</guid>
</item><item>
<title>Natco Pharma challenges patent on Tamiflu</title>
<link>http://www.internationaldrugmart.com/news-section/natco-pharma-challenges-patent-on-tamiflu.shtml</link>
<description>Natco Pharma has challenged a patent on Tamiflu (Oseltamivir Phosphate)—a drug used in the treatment of bird and swine-flu infections, reports the PTI.</description>
<pubDate>2011-02-17</pubDate>
<guid>natco-pharma-challenges-patent-on-tamiflu.shtml</guid>
</item><item>
<title>Neuralstem gets US FDA orphan drug status for spinal cord stem cells for ALS treatment</title>
<link>http://www.internationaldrugmart.com/news-section/neuralstem-gets-us-fda-orphan-drug-status-for-spinal-cord-stem-cells-for-als-treatment.shtml</link>
<description>Neuralstem, Inc.  announced that the US Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (</description>
<pubDate>2011-02-17</pubDate>
<guid>neuralstem-gets-us-fda-orphan-drug-status-for-spinal-cord-stem-cells-for-als-treatment.shtml</guid>
</item><item>
<title>AstraZeneca, Taj Pharma launch Gemcitabine HCI for Injection in US</title>
<link>http://www.internationaldrugmart.com/news-section/astrazeneca-taj-pharma-launch-gemcitabine-hcl-for-injection-in-us.shtml</link>
<description>AstraZeneca Pharmaceuticals and Taj Pharmaceuticals, an India-based manufacturer of generic drugs as well as specialty pharmaceuticals and active pharmaceutical ingredients, have commercially launched</description>
<pubDate>2011-02-08</pubDate>
<guid>astrazeneca-taj-pharma-launch-gemcitabine-hcl-for-injection-in-us.shtml</guid>
</item><item>
<title>FDA Approves First Drug to Prevent Premature Births</title>
<link>http://www.internationaldrugmart.com/news-section/fda-approves-first-drug-to-prevent-premature-births.shtml</link>
<description>The U.S. Food and Drug Administration has approved the first drug to help prevent premature birth in women who have had at least one previous preterm delivery.</description>
<pubDate>2011-02-08</pubDate>
<guid>fda-approves-first-drug-to-prevent-premature-births.shtml</guid>
</item><item>
<title>FDA approves gardasil for anal cancer prevention</title>
<link>http://www.internationaldrugmart.com/news-section/fda-approves-gardasil-for-anal-cancer-prevention.shtml</link>
<description>FDA has approved Gardasil HPV vaccine for the prevention of anal cancer in men and women aged 9 through 26 years. Gardasil is already approved for preventing cervical , vaginal and vulvar cancers in w</description>
<pubDate>2011-02-08</pubDate>
<guid>fda-approves-gardasil-for-anal-cancer-prevention.shtml</guid>
</item><item>
<title>Nestle buys UK-based CM&D Pharma</title>
<link>http://www.internationaldrugmart.com/news-section/nestle-buys-uk-based-cm-and-d-pharma.shtml</link>
<description>Swiss food giant Nestle has acquired CM&D Pharma, a UK-based drug maker that specialises in the development of products tailored for patients with kidney disease, for an undisclosed amount.</description>
<pubDate>2011-02-08</pubDate>
<guid>nestle-buys-uk-based-cm-and-d-pharma.shtml</guid>
</item><item>
<title>Sun Pharma receives USFDA nod for generic Alzheimer's drug</title>
<link>http://www.internationaldrugmart.com/news-section/sun-pharma-receives-usfda-nod-for-generic-alzheimers-drug.shtml</link>
<description>Drug firm Sun Pharmaceutical Industries today said it has received a tentative approval from US health regulator to market generic donepezil hydrochloride tablets used for treating Alzheimer's disease</description>
<pubDate>2011-02-08</pubDate>
<guid>sun-pharma-receives-usfda-nod-for-generic-alzheimers-drug.shtml</guid>
</item><item>
<title>Analysis: Pfizer post-Lipitor twists could cushion blow</title>
<link>http://www.internationaldrugmart.com/news-section/analysis-pfizer-post-lipitor-twists-could-cushion-blow.shtml</link>
<description>(Reuters) - Pfizer Inc's loss this November of exclusive U.S. rights to its best-selling Lipitor cholesterol treatment is one of the most anticipated events in the drug industry's history, but the ini</description>
<pubDate>2011-02-03</pubDate>
<guid>analysis-pfizer-post-lipitor-twists-could-cushion-blow.shtml</guid>
</item><item>
<title>AstraZeneca's Nasal Flu Vaccine Approved In Europe</title>
<link>http://www.internationaldrugmart.com/news-section/astrazenecas-nasal-flu-vaccine-approved-in-europe.shtml</link>
<description>LONDON -(Dow Jones)- AstraZeneca PLC (AZN) Tuesday said its nasal flu vaccine has been approved in Europe for children and adolescents, but is unlikely to go on sale until 2012.</description>
<pubDate>2011-02-03</pubDate>
<guid>astrazenecas-nasal-flu-vaccine-approved-in-europe.shtml</guid>
</item><item>
<title>Aurobindo Pharma receives USFDA approval</title>
<link>http://www.internationaldrugmart.com/news-section/aurobindo-pharma-receives-usfda-approval.shtml</link>
<description>Aurobindo Pharma has received tentative approval from the USFDA to manufacture and market Famciclovir tablets in the strengths of 125mg, 250mg and 500mg.</description>
<pubDate>2011-02-03</pubDate>
<guid>aurobindo-pharma-receives-usfda-approval.shtml</guid>
</item><item>
<title>Avandia Lawsuit Settled by GlaxoSmithKline Day Before Scheduled Trial</title>
<link>http://www.internationaldrugmart.com/news-section/avandia-lawsuit-settled-by-glaxosmithkline-day-before-scheduled-trial.shtml</link>
<description>On January 31, British drug manufacturer GlaxoSmithKline settled a U.S. federal court case involving popular diabetes drug  Avandia the day before it was scheduled to go to trial. The lawsuit claimed </description>
<pubDate>2011-02-03</pubDate>
<guid>avandia-lawsuit-settled-by-glaxosmithkline-day-before-scheduled-trial.shtml</guid>
</item><item>
<title>Novartis To Acquire Genoptix</title>
<link>http://www.internationaldrugmart.com/news-section/novartis-to-acquire-genoptix.shtml</link>
<description>Novartis is looking to advance its personalized medicine treatment programs by entering into a definitive agreement to acquire Genoptix, a laboratory offering personalized diagnostic services, for app</description>
<pubDate>2011-02-03</pubDate>
<guid>novartis-to-acquire-genoptix.shtml</guid>
</item><item>
<title>GlaxoSmithKline Starts 2 Phase III Studies In Advanced/Metastatic Melanoma</title>
<link>http://www.internationaldrugmart.com/news-section/glaxosmithkline-starts-2-phase-3-studies-in-advanced-metastatic-melanoma.shtml</link>
<description>LONDON (Dow Jones)--GlaxoSmithKline (GSK.LN), the drug giant, Monday announced the start of two global Phase III studies in advanced or metastatic melanoma patients with a BRAF V600 mutation.</description>
<pubDate>2011-01-25</pubDate>
<guid>glaxosmithkline-starts-2-phase-3-studies-in-advanced-metastatic-melanoma.shtml</guid>
</item><item>
<title>Glenmark: Unit Gets FDA OK To Sell Generic Malaria Drug</title>
<link>http://www.internationaldrugmart.com/news-section/glenmark-unit-gets-fda-ok-to-sell-generic-malaria-drug.shtml</link>
<description>BANGALORE (Dow Jones)--Glenmark Pharmaceuticals Ltd. (532296.BY) Wednesday said its generic drugs unit has received final approval from the U.S. Food and Drug Administration to sell a generic version </description>
<pubDate>2011-01-25</pubDate>
<guid>glenmark-unit-gets-fda-ok-to-sell-generic-malaria-drug.shtml</guid>
</item><item>
<title>Ranbaxy Ends Drug Discovery Pact With Merck</title>
<link>http://www.internationaldrugmart.com/news-section/ranbaxy-ends-drug-discovery-pact-with-merck.shtml</link>
<description>BANGALORE -- Ranbaxy Laboratories Ltd. has discontinued a drug discovery and clinical development collaboration with Merck & Co. Inc. aimed at developing new anti-bacterial and anti-fungal drugs, a sp</description>
<pubDate>2011-01-25</pubDate>
<guid>ranbaxy-ends-drug-discovery-pact-with-merck.shtml</guid>
</item><item>
<title>FDA warning links Multaq to severe liver injury </title>
<link>http://www.internationaldrugmart.com/news-section/fda-warning-links-multaq-to-severe-liver-injury.shtml</link>
<description>The FDA  is alerting healthcare professionals and patients about cases of rare, but severe liver injury, including two cases of acute liver failure leading to liver transplants in patients treated wit</description>
<pubDate>2011-01-19</pubDate>
<guid>fda-warning-links-multaq-to-severe-liver-injury.shtml</guid>
</item><item>
<title> Lincoln Pharma gets patent approval for nasal spray treatment </title>
<link>http://www.internationaldrugmart.com/news-section/lincoln-pharma-gets-patent-approval-for-nasal-spray-treatment.shtml</link>
<description>NEW DELHI: Lincoln Pharmaceuticals on Monday said it has received patent approval for a nasal spray , which would help prevent vomiting and nausea.</description>
<pubDate>2011-01-19</pubDate>
<guid>lincoln-pharma-gets-patent-approval-for-nasal-spray-treatment.shtml</guid>
</item><item>
<title>Recall of Tylenol, Benadryl, Sudafed, Sinutab Issued Over Sanitary Problems</title>
<link>http://www.internationaldrugmart.com/news-section/recall-of-tylenol-benadryl-sudafed-sinutab-issued-over-sanitary-problems.shtml</link>
<description>Johnson & Johnson has issued another recall involving Tylenol, Benadryl, Sudafed and Sinutab over-the-counter (OTC) drugs after finding that equipment at a McNeil Healthcare manufacturing plant where </description>
<pubDate>2011-01-19</pubDate>
<guid>recall-of-tylenol-benadryl-sudafed-sinutab-issued-over-sanitary-problems.shtml</guid>
</item><item>
<title>Abstral transmucosal tablets receives FDA approval to manage pain in cancer patients</title>
<link>http://www.internationaldrugmart.com/news-section/abstral-transmucosal-tablets-receives-fda-approval.shtml</link>
<description>The U.S. Food and Drug Administration today approved Abstral (fentanyl) transmucosal tablets to manage breakthrough pain for adults with cancer. Fentanyl immediate-release transmucosal medications are</description>
<pubDate>2011-01-10</pubDate>
<guid>abstral-transmucosal-tablets-receives-fda-approval.shtml</guid>
</item><item>
<title>FDA Announces Recall of Alcohol Prep Pads, Swabs, Swabsticks </title>
<link>http://www.internationaldrugmart.com/news-section/fda-announces-recall-of-alcohol-prep-pads-swabs-swabsticks.shtml</link>
<description>Healthcare professionals and consumers should stop using all alcohol prep pads, alcohol swabs and alcohol swabsticks manufactured by Triad Group and sold under private labels at the consumer level, ac</description>
<pubDate>2011-01-10</pubDate>
<guid>fda-announces-recall-of-alcohol-prep-pads-swabs-swabsticks.shtml</guid>
</item><item>
<title>FDA Cancer Division Head Defends Avastin Decision </title>
<link>http://www.internationaldrugmart.com/news-section/fda-cancer-division-head-defends-avastin-decision.shtml</link>
<description>Defending Decision: The head of the FDA’s cancer-drug division defended the agency’s proposal to strip Genentech’s Avastin of its marketing approval for breast cancer, the WSJ reports. Richard P</description>
<pubDate>2011-01-10</pubDate>
<guid>fda-cancer-division-head-defends-avastin-decision.shtml</guid>
</item><item>
<title></title>
<link>http://www.internationaldrugmart.com/news-section/generics-as-effective-as-brand-medications-banner.html</link>
<description>Why Your US Pharmacist and Your US Physician will not Tell you The Truth About Indian Generic Medication</description>
<pubDate>2011-01-01</pubDate>
<guid>generics-as-effective-as-brand-medications-banner.html</guid>
</item><item>
<title>Glenmark gets USFDA nod for lithium carbonate</title>
<link>http://www.internationaldrugmart.com/news-section/glenmark-gets-usfda-nod-for-lithium-carbonate.shtml</link>
<description>The US subsidiary of Glenmark Generics today said that they have been granted final abbreviated new drug application (ANDA) approval by the United States Food and Drug Administration (USFDA) for Lithi</description>
<pubDate>2010-12-29</pubDate>
<guid>glenmark-gets-usfda-nod-for-lithium-carbonate.shtml</guid>
</item><item>
<title>GSK Bets on Outcome of Kidney Cancer Trial</title>
<link>http://www.internationaldrugmart.com/news-section/gsk-bets-on-outcome-of-kidney-cancer-trial.shtml</link>
<description>GlaxoSmithKline is literally putting money on the outcome of a clinical trial now in progress, pitting its pazopanib (Votrient) for advanced renal cell carcinoma against sunitinib (Sutent).</description>
<pubDate>2010-12-29</pubDate>
<guid>gsk-bets-on-outcome-of-kidney-cancer-trial.shtml</guid>
</item><item>
<title>J&amp;J, AstraZeneca Halt Tests on Bone-Damage Concerns</title>
<link>http://www.internationaldrugmart.com/news-section/j-j-astrazeneca-halt-tests-on-bone-damage-concerns.shtml</link>
<description>Johnson &amp; Johnson and AstraZeneca Plc stopped studies of experimental painkillers over concerns that a class of drugs once expected to generate as much as $11 billion in annual sales may raise the</description>
<pubDate>2010-12-29</pubDate>
<guid>j-j-astrazeneca-halt-tests-on-bone-damage-concerns.shtml</guid>
</item><item>
<title>Kidney disease patients better off on vegetarian diet</title>
<link>http://www.internationaldrugmart.com/news-section/kidney-disease-patients-better-off-on-vegetarian-diet.shtml</link>
<description>New research indicates kidney patients may benefit greatly from adhering to a vegetarian diet.</description>
<pubDate>2010-12-29</pubDate>
<guid>kidney-disease-patients-better-off-on-vegetarian-diet.shtml</guid>
</item><item>
<title>Asthmatics living in poverty suffer more</title>
<link>http://www.internationaldrugmart.com/news-section/asthmatics-living-in-poverty-suffer-more.shtml</link>
<description>The report from the UCLA Center for Health Policy Research found that of the more than 600,000 Californians who experience frequent — daily or weekly — symptoms that can signal uncontrolled asthma</description>
<pubDate>2010-12-21</pubDate>
<guid>asthmatics-living-in-poverty-suffer-more.shtml</guid>
</item><item>
<title>Glenmark unit gets FDA nod for felodipine tablets</title>
<link>http://www.internationaldrugmart.com/news-section/glenmark-unit-gets-fda-nod-for-felodipine-tablets.shtml</link>
<description>MUMBAI (MarketWatch) -- Glenmark Pharmaceuticals Ltd. (532296.BY) Monday said its unit received a final approval from the U.S. Food and Drug Administration for felodipine extended-release tablets--the</description>
<pubDate>2010-12-21</pubDate>
<guid>glenmark-unit-gets-fda-nod-for-felodipine-tablets.shtml</guid>
</item><item>
<title>New warnings about bone-strengthening drugs</title>
<link>http://www.internationaldrugmart.com/news-section/new-warnings-about-bone-strengthening-drugs.shtml</link>
<description>Warren Buffett, the world's greatest investor, says, "Risk comes from not knowing what you're doing." What is true in economics is equally true in medicine, particularly so when taking medication. A r</description>
<pubDate>2010-12-21</pubDate>
<guid>new-warnings-about-bone-strengthening-drugs.shtml</guid>
</item><item>
<title>Popular Treatment to Avert Chemo Nausea may Lead to Imbalance in Heart Rhythm: FDA</title>
<link>http://www.internationaldrugmart.com/news-section/popular-treatment-to-avert-chemo-nausea-may-lead-to-lmbalance-in-heart-rhythm-fda.shtml</link>
<description>The US Food and Drug Administration (FDA) has warned that the popular form of treatment of injecting Anzemet (dolasetron mesylate) in order to overcome nausea and vomiting among chemotherapy patients </description>
<pubDate>2010-12-21</pubDate>
<guid>popular-treatment-to-avert-chemo-nausea-may-lead-to-lmbalance-in-heart-rhythm-fda.shtml</guid>
</item><item>
<title>U.S. Postal Service Ready for Busiest Mailing Day</title>
<link>http://www.internationaldrugmart.com/news-section/us-postal-service-ready-for-busiest-mailing-day.shtml</link>
<description>WASHINGTON — Monday, Dec. 20, marks the Postal Service’s busiest mailing day of the year with more than 800 million pieces of mail expected to enter the system. This represents a 40 percent increa</description>
<pubDate>2010-12-21</pubDate>
<guid>us-postal-service-ready-for-busiest-mailing-day.shtml</guid>
</item><item>
<title>Energy Drinks + Booze = DISASTER!</title>
<link>http://www.internationaldrugmart.com/news-section/energy-drinks-booze-disaster.shtml</link>
<description>Do you drink self-mixed or premixed energy drinks containing alcohol?  A recent FDA crack down on alcoholic energy drinks such as High Gravity HG, High Gravity HG Orange and Lemon Lime, Spiked Moonsho</description>
<pubDate>2010-12-14</pubDate>
<guid>energy-drinks-booze-disaster.shtml</guid>
</item><item>
<title>FDA Approves Weight Loss Drug: Is the Magic Pill Here?</title>
<link>http://www.internationaldrugmart.com/news-section/fda-approves-weight-loss-drug.shtml</link>
<description>A panel of FDA advisers has recommended approval for Contrave, a new weight-loss drug that combines antidepressant and anti-alcoholism medications to help people lose ... wait for it ... a whopping 4.</description>
<pubDate>2010-12-14</pubDate>
<guid>fda-approves-weight-loss-drug.shtml</guid>
</item><item>
<title>Mylan receives US FDA approval for generic Adalat CC tablets</title>
<link>http://www.internationaldrugmart.com/news-section/mylan-receives-usfda-approval-for-generic-adalat-cc-tablets.shtml</link>
<description>Mylan Inc. announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nifed</description>
<pubDate>2010-12-14</pubDate>
<guid>mylan-receives-usfda-approval-for-generic-adalat-cc-tablets.shtml</guid>
</item><item>
<title>Reckitt Benckiser to buy India's Paras Pharma</title>
<link>http://www.internationaldrugmart.com/news-section/reckitt-benckiser-to-buy-indias-paras-pharma.shtml</link>
<description>British consumer goods company Reckitt Benckiser said on Sunday it agreed to buy privately held Indian firm Paras Pharmaceuticals for Rs 3260 crore (USD 726 mn).</description>
<pubDate>2010-12-14</pubDate>
<guid>reckitt-benckiser-to-buy-indias-paras-pharma.shtml</guid>
</item><item>
<title>Watson Pharma seeking India acquisitions: report</title>
<link>http://www.internationaldrugmart.com/news-section/watson-pharma-seeking-india-acquisitions-report.shtml</link>
<description>By Mumbai Bureau:MUMBAI (MarketWatch) -- Watson Pharmaceuticals Inc. /quotes/comstock/13*!wpi/quotes/nls/wpi (WPI 48.84, +0.18, +0.37%) is looking to enter the Indian pharmaceutical market by acquirin</description>
<pubDate>2010-12-14</pubDate>
<guid>watson-pharma-seeking-india-acquisitions-report.shtml</guid>
</item><item>
<title>Aurobindo Pharma Gets USFDA Approval For Duloxetine Hydrochloride Capsules </title>
<link>http://www.internationaldrugmart.com/news-section/aurobindo-pharma-usfda-approval-duloxetine-hydrochloride.shtml</link>
<description>(RTTNews) - The Hyderabad-based Aurobindo Pharma Ltd. announced that the company had received tentative approval from the US FDA to manufacture and market Duloxetine Hydrochloride Delayed-Release caps</description>
<pubDate>2010-12-08</pubDate>
<guid>aurobindo-pharma-usfda-approval-duloxetine-hydrochloride.shtml</guid>
</item><item>
<title>GlaxoSmithKline and Human Genome Sciences announce FDA extension of Benlysta </title>
<link>http://www.internationaldrugmart.com/news-section/glaxosmithkline-human-genome-sciences-fda-extension-benlysta.shtml</link>
<description>December 08, 2010</description>
<pubDate>2010-12-08</pubDate>
<guid>glaxosmithkline-human-genome-sciences-fda-extension-benlysta.shtml</guid>
</item><item>
<title>Glenmark gets US FDA nod to sell painkiller drug in US</title>
<link>http://www.internationaldrugmart.com/news-section/glenmark-gets-usfda-nod-to-sell-painkiller-drug-in-us.shtml</link>
<description>New DelhiDrug maker Glenmark today said it along with its US-based partner has got the US health regulator's nod to manufacture and market two oxycodone products, used for treating moderate to severe </description>
<pubDate>2010-12-08</pubDate>
<guid>glenmark-gets-usfda-nod-to-sell-painkiller-drug-in-us.shtml</guid>
</item><item>
<title>Local Medicine Climbs Another Rung on FDA Ladder</title>
<link>http://www.internationaldrugmart.com/news-section/local-medicine-climbs-another-rung-on-fda-ladder.shtml</link>
<description>BUFFALO (wned) - Buffalo-based drug maker Cleveland Biolabs has been working on a medicine to protect against radiation poisoning for more than seven years. And this week the drug, CBLB502, took anoth</description>
<pubDate>2010-12-08</pubDate>
<guid>local-medicine-climbs-another-rung-on-fda-ladder.shtml</guid>
</item><item>
<title>Obesity Surgery, Greed and US FDA Approval</title>
<link>http://www.internationaldrugmart.com/news-section/obesity-surgery-greed-and-usfda-approval.shtml</link>
<description>Any surgey is never without risk and should only be the last option. Recently obesity surgery was recommended by a panel of US Food and Drug Administration experts and they said that even non-severely</description>
<pubDate>2010-12-08</pubDate>
<guid>obesity-surgery-greed-and-usfda-approval.shtml</guid>
</item><item>
<title>Brain illness research gets boost </title>
<link>http://www.internationaldrugmart.com/news-section/brain-illness-research-gets-boost.shtml</link>
<description>Rutgers University is collaborating with Big Pharma to study some of the most perplexing brain pathologies of our time: autism, Alzheimer's disease, schizophrenia and some types of age-related hearing</description>
<pubDate>2010-11-30</pubDate>
<guid>brain-illness-research-gets-boost.shtml</guid>
</item><item>
<title>Dr Reddy's buys GSK's oral penicillin facility in US</title>
<link>http://www.internationaldrugmart.com/news-section/dr-reddys-buys-gsk-oral-penicillin-facility-in-us.shtml</link>
<description>US-based pharma major GlaxoSmithKline and Indian drug giant Dr Reddy’s Laboratories, have signed an agreement relating to GSK’s United States oral penicillin facility and product portfolio. Under </description>
<pubDate>2010-11-30</pubDate>
<guid>dr-reddys-buys-gsk-oral-penicillin-facility-in-us.shtml</guid>
</item><item>
<title>GSK & JSC Binnopharm enter vaccine production alliance in Russia</title>
<link>http://www.internationaldrugmart.com/news-section/gsk-jsc-binnopharm-enter-vaccine-production-alliance-in-russia.shtml</link>
<description>GlaxoSmithKline (GSK) and JSC Binnopharm announced an alliance to enable the local secondary manufacture of a number of GSK vaccines in Russia. The agreement was signed in Moscow during the session of</description>
<pubDate>2010-11-30</pubDate>
<guid>gsk-jsc-binnopharm-enter-vaccine-production-alliance-in-russia.shtml</guid>
</item><item>
<title>Ranbaxy gets nod for Alzheimer’s drug</title>
<link>http://www.internationaldrugmart.com/news-section/ranbaxy-gets-nod-for-alzheimers-drug.shtml</link>
<description>Ranbaxy Laboratories Ltd, India’s largest pharmaceutical company by revenue, has received the US drug regulator’s nod to launch its generic version of Pfizer Inc. and Eisai Co. Ltd’s Alzheimer</description>
<pubDate>2010-11-30</pubDate>
<guid>ranbaxy-gets-nod-for-alzheimers-drug.shtml</guid>
</item><item>
<title>Top 100 pharma cos report 20% growth in profits in July-September: Pharmabiz study</title>
<link>http://www.internationaldrugmart.com/news-section/top-100pharma-cos-report-20percent-growth-in-profits.shtml</link>
<description>India's top 100 Indian pharmaceutical companies have posted a satisfactory growth rate in top line as well as bottom line during the quarter ended September 2010 despite several hurdles in highly regu</description>
<pubDate>2010-11-30</pubDate>
<guid>top-100pharma-cos-report-20percent-growth-in-profits.shtml</guid>
</item><item>
<title>ACT wins FDA’s approval to test stem cell therapy</title>
<link>http://www.internationaldrugmart.com/news-section/act-wins-fda-approval-to-test-stem-cell-therapy.shtml</link>
<description>Advanced Cell Technology, a stem cell company with a research laboratory in Marlborough, has received federal approval to test a human embryonic stem cell treatment on patients with a rare disease tha</description>
<pubDate>2010-11-23</pubDate>
<guid>act-wins-fda-approval-to-test-stem-cell-therapy.shtml</guid>
</item><item>
<title>Better GERD diagnosis, treatment pushed</title>
<link>http://www.internationaldrugmart.com/news-section/better-gerd-diagnosis-treatment-pushed.shtml</link>
<description>MANILA, Philippines - Research-based pharmaceutical company AstraZeneca is working with specialists to “localize” a patient questionnaire that can help primary care physicians better diagnose gast</description>
<pubDate>2010-11-23</pubDate>
<guid>better-gerd-diagnosis-treatment-pushed.shtml</guid>
</item><item>
<title>Could This Kill Cancer?</title>
<link>http://www.internationaldrugmart.com/news-section/could-this-kill-cancer.shtml</link>
<description>When Hendrik Luesch invited me to Florida to go snorkeling, I didn’t expect to be wading through brackish muck in the Indian River Lagoon, a 156-mile-long estuary. I’m traveling aboard a 21-foot f</description>
<pubDate>2010-11-23</pubDate>
<guid>could-this-kill-cancer.shtml</guid>
</item><item>
<title>New path for colon cancer drug discovery</title>
<link>http://www.internationaldrugmart.com/news-section/new-path-for-colon-cancer-drug-discovery.shtml</link>
<description>An old pinworm medicine is a new lead in the search for compounds that block a signaling pathway implicated in colon cancer. The findings, reported by Vanderbilt University Medical Center researchers </description>
<pubDate>2010-11-23</pubDate>
<guid>new-path-for-colon-cancer-drug-discovery.shtml</guid>
</item><item>
<title>2 Treatments for Retinas Make Gains</title>
<link>http://www.internationaldrugmart.com/news-section/treatments-for-retinas-make-gains.shtml</link>
<description>LOS ANGELES — Elderly people losing their vision from age-related macular degeneration might one day have a treatment option that requires fewer injections into the eye than the standard drug now us</description>
<pubDate>2010-11-23</pubDate>
<guid>treatments-for-retinas-make-gains.shtml</guid>
</item><item>
<title>Emkay reiterates Buy on Aurobindo Pharma</title>
<link>http://www.internationaldrugmart.com/news-section/emkay-reiterates-buy-on-aurobindo-pharma.shtml</link>
<description>  Emkay  has recommended Buy on Aurobindo Pharma with a price target of Rs 1,581 as against the market price (CMP) of Rs 1,343 in its report dated Nov 9, 2010.</description>
<pubDate>2010-11-15</pubDate>
<guid>emkay-reiterates-buy-on-aurobindo-pharma.shtml</guid>
</item><item>
<title>GlaxoSmithKline, Fiocruz To Develop New Medicines For Tropical Diseases</title>
<link>http://www.internationaldrugmart.com/news-section/glaxosmithkline-fiocruz-to-develop-new-medicines-for-tropical-diseases.shtml</link>
<description> LONDON -(Dow Jones)- GlaxoSmithKline PLC (GSK.LN), and the Oswald Cruz Foundation or Fiocruz Friday announced a unique collaboration to research and develop new and innovative medicines to treat dise</description>
<pubDate>2010-11-15</pubDate>
<guid>glaxosmithkline-fiocruz-to-develop-new-medicines-for-tropical-diseases.shtml</guid>
</item><item>
<title>India Ranbaxy Q3 profit jumps, beats forecast</title>
<link>http://www.internationaldrugmart.com/news-section/india-ranbaxy-q3-profit-jumps-beats-forecast.shtml</link>
<description>  Ranbaxy, controlled by Japan's Daiichi Sankyo (4568.T), said consolidated net profit stood at 3.08 billion rupees ($69.5 million) for the fiscal third-quarter ended September. This compared with 1.1</description>
<pubDate>2010-11-15</pubDate>
<guid>india-ranbaxy-q3-profit-jumps-beats-forecast.shtml</guid>
</item><item>
<title>APP Pharmaceuticals to Launch Drug Hotline</title>
<link>http://www.internationaldrugmart.com/news-section/app-pharmaceuticals-to-launch-drug-hotline.shtml</link>
<description>APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., /quotes/comstock/15*!apcvz/quotes/nls/apcvz (APCVZ 0.04, 0.00, -2.63%) announced today that it wil</description>
<pubDate>2010-11-10</pubDate>
<guid>app-pharmaceuticals-to-launch-drug-hotline.shtml</guid>
</item></channel></rss>
